Next Article in Journal
Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4
Previous Article in Journal
BX795-Organic Acid Coevaporates: Evaluation of Solid-State Characteristics, In Vitro Cytocompatibility and In Vitro Activity against HSV-1 and HSV-2
Previous Article in Special Issue
Future Perspectives of Oral Delivery of Next Generation Therapies for Treatment of Skin Diseases
 
 
Article

Article Versions Notes

Pharmaceutics 2021, 13(11), 1921; https://doi.org/10.3390/pharmaceutics13111921
Action Date Notes Link
article xml file uploaded 12 November 2021 17:50 CET Original file -
article xml uploaded. 12 November 2021 17:50 CET Update -
article pdf uploaded. 12 November 2021 17:50 CET Version of Record https://www.mdpi.com/1999-4923/13/11/1921/pdf-vor
article html file updated 12 November 2021 17:51 CET Original file -
article xml file uploaded 15 November 2021 10:57 CET Update -
article xml uploaded. 15 November 2021 10:57 CET Update -
article pdf uploaded. 15 November 2021 10:57 CET Updated version of record https://www.mdpi.com/1999-4923/13/11/1921/pdf-vor
article html file updated 15 November 2021 10:58 CET Update -
article xml file uploaded 18 November 2021 09:56 CET Update -
article xml uploaded. 18 November 2021 09:56 CET Update -
article pdf uploaded. 18 November 2021 09:56 CET Updated version of record https://www.mdpi.com/1999-4923/13/11/1921/pdf-vor
article html file updated 18 November 2021 09:57 CET Update -
article xml file uploaded 22 November 2021 09:26 CET Update -
article xml uploaded. 22 November 2021 09:26 CET Update https://www.mdpi.com/1999-4923/13/11/1921/xml
article pdf uploaded. 22 November 2021 09:26 CET Updated version of record https://www.mdpi.com/1999-4923/13/11/1921/pdf
article html file updated 22 November 2021 09:27 CET Update -
article html file updated 30 July 2022 16:25 CEST Update https://www.mdpi.com/1999-4923/13/11/1921/html
Back to TopTop